Skip to main content
. 2016 Jul 21;45(7):721–733. doi: 10.1007/s00249-016-1152-z

Fig. 2.

Fig. 2

Binding of mAb62-Cy5.5 to Kv10.1-expressing tumours. Representative a in vivo and b ex vivo scans of MDA-MB-435S and AsPC-1 subcutaneous tumours 24 h after i.v. injection of mAb62-Cy5.5. High fluorescence intensity was observed over the Kv10.1-expressing MDA-MB-435S tumour (arrow), whereas the control AsPC1 tumour (arrow) showed much lower fluorescence in both in vivo and ex vivo scans. Intensity is depicted in normalised counts (NC)